Rongchang Biotech (09995) issued an announcement. According to the company's operating needs and financial situation, the company plans to go to the bank in 2024...
Zhitong Finance App News, Rongchang Biotech (09995) issued an announcement. According to the company's operating requirements and financial situation, the company plans to apply for a comprehensive credit line totaling not more than 5.5 billion yuan (or foreign currency equivalent) from banks and other financial institutions in 2024. The types of credit loans include but are not limited to short-term working capital loans, project loans, medium- and long-term loans, bank acceptance notes, guarantees, etc. The specific credit business type, credit period and amount are subject to the final contract or agreement signed between the company and the relevant financial institutions.
The above credit amount is not equal to the company's actual financing amount. The specific financing amount is within the comprehensive credit limit and is based on the actual financing amount generated by banks and other financial institutions and companies. The specific amount and type of financing will be reasonably determined according to the actual needs of the company's business development. During the credit period, the credit line is jointly used by the company and its wholly-owned subsidiary on a rolling basis, and can be recycled. The credit line is valid from the date of review and approval by the board of directors this time until the date the board resolution to review the credit limit for the next year is passed.